Jahan, F., Penna, L., Luostarinen, A., Veltman, L., Hongisto, H., Lähteenmäki, K., . . . Kerkelä, E. Automated and closed clinical-grade manufacturing protocol produces potent NK cells against neuroblastoma cells and AML blasts. Nature Portfolio.
Chicago Style (17th ed.) CitationJahan, Farhana, et al. Automated and Closed Clinical-grade Manufacturing Protocol Produces Potent NK Cells Against Neuroblastoma Cells and AML Blasts. Nature Portfolio.
MLA (9th ed.) CitationJahan, Farhana, et al. Automated and Closed Clinical-grade Manufacturing Protocol Produces Potent NK Cells Against Neuroblastoma Cells and AML Blasts. Nature Portfolio.
Warning: These citations may not always be 100% accurate.